Alpha Cognition (ACOG) Depreciation & Amortization (CF) (2023 - 2025)
Alpha Cognition (ACOG) posted quarterly Depreciation & Amortization (CF) of $27123.0 for Q4 2025, up 32.99% year-over-year from $20395.0 in Q4 2024, and up 116.07% quarter-over-quarter from $12553.0 in Q3 2025.
Alpha Cognition (ACOG) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
Alpha Cognition's Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $27123.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) rose 32.99% year-over-year to $27123.0; the TTM figure through Dec 2025 stood at $58572.0 (down 27.88% YoY), while the FY2025 annual figure was $58572.0, down 27.88% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $27123.0, up from $12553.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $27123.0 in Q4 2025, with the low at $526.0 in Q2 2023.
- The 3-year median for Depreciation & Amortization (CF) is $19997.0 (2024), against an average of $16596.1.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) surged 3701.71% in 2024, then plunged 65.04% in 2025.
- Alpha Cognition's Depreciation & Amortization (CF) stood at $21120.0 in 2023, then dropped by 3.43% to $20395.0 in 2024, then surged by 32.99% to $27123.0 in 2025.
- Business Quant data shows ACOG's Depreciation & Amortization (CF) at $27123.0 in Q4 2025, $12553.0 in Q3 2025, and $11614.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,123.00 |
| Dec 31, 2025 | 27,123.00 |
| Sep 30, 2025 | 12,553.00 |
| Sep 30, 2025 | 12,553.00 |
| Jun 30, 2025 | 11,614.00 |
| Jun 30, 2025 | 11,614.00 |
| Mar 31, 2025 | 7,282.00 |
| Mar 31, 2025 | 7,282.00 |
| Dec 31, 2024 | 20,395.00 |
| Dec 31, 2024 | 20,395.00 |
| Sep 30, 2024 | 19,997.00 |
| Sep 30, 2024 | 19,997.00 |
| Jun 30, 2024 | 19,997.00 |
| Jun 30, 2024 | 19,997.00 |
| Mar 31, 2024 | 20,831.00 |
| Mar 31, 2024 | 20,831.00 |
| Dec 31, 2023 | 21,120.00 |
| Dec 31, 2023 | 21,120.00 |
| Sep 30, 2023 | 21,119.00 |
| Sep 30, 2023 | 21,119.00 |